| Literature DB >> 6642068 |
A B Tattersall, K M Bridgman, A Huitson.
Abstract
The results of this general practice study suggest that acetylcysteine (Fabrol) administered orally for 2 months to patients with chronic bronchitis effectively changes the viscosity and character of sputum with resultant ease of expectoration and cough severity. There was a notable improvement in associated abnormal physical signs such as the presence of rhonchi, crepitations and symptoms including dyspnoea at rest. Tolerability was good, with 81% of patients experiencing no side-effects.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6642068 DOI： 10.1177/030006058301100505
Source DB: PubMed Journal: J Int Med Res ISSN： 0300-0605 Impact factor: 1.671